Kim Y, Keogh JB, Clifton PM
As patents expire and potential generic or biosimilar versions emerge (e.g., generic liraglutide by Teva in 2024 ( [68] )), costs might come down, but for newer agents like semaglutide or tirzepatide, it could be years
This is called extra-label or off-label use because this use isnt described on the drug label
The letter should include your diagnosis and current disease status, treatments tried and why they were inadequate, specific reasons why Ozempic is the appropriate choice, clinical evidence supporting Ozempic for your condition, and potential health consequences if Ozempic is not approved
Theyre less likely to get put on blood pressure-lowering medications
At Live Oak Weight Loss, we grasp that each weight loss journey is unique